Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2013
03/14/2013WO2013035779A1 Method of analysis of intercell interactions
03/14/2013WO2013034670A1 Preparation of micafungin intermediates
03/14/2013WO2013034506A1 Pde10 modulators
03/14/2013WO2013034238A1 Benzonitrile derivatives as kinase inhibitors
03/14/2013WO2013034047A1 Heterocyclic-substitued benzofuran derivatives and methods of use thereof for the treatment of viral diseases
03/14/2013WO2013013113A3 Histone deacetylase 6 selective inhibitors for the treatment of bone disease
03/14/2013WO2012173682A3 Compounds and methods for the treatment of isocitrate dehydrognase related diseases
03/14/2013WO2012157980A9 Manufacturing method of azilsartan
03/14/2013WO2012157977A9 Manufacturing method of heterocyclic compound
03/14/2013WO2012063269A3 Process for preparing iloperidone
03/14/2013WO2011128388A3 Oxazole and thiazole compounds as ksp inhibitors
03/14/2013WO2010062171A3 Cc-1065 analogs and their conjugates
03/14/2013US20130066076 Process for the Synthesis of Biaryl Oxazolidinones
03/14/2013US20130066069 Processes for preparing substituted pyrimidines
03/14/2013US20130065923 Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
03/14/2013US20130065918 Soluble guanylate cyclase activators
03/14/2013US20130065911 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides
03/14/2013US20130065907 5-cycloalkyl- or 5-heterocyclyl-nicotinamides
03/14/2013US20130065906 New compounds, pharmaceutical compositions and uses thereof
03/14/2013US20130065905 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
03/14/2013US20130065902 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
03/14/2013US20130065900 Pharmaceutical compounds
03/14/2013US20130065897 Compounds, preparation and uses thereof
03/14/2013US20130065896 Fused imidazole derivative
03/14/2013US20130065894 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS
03/14/2013US20130065882 VLA-4 inhibitory drug
03/14/2013US20130065880 Compounds as tyrosine kinase modulators
03/14/2013US20130065879 Heteroaryl compounds and uses thereof
03/14/2013US20130065877 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
03/14/2013US20130065876 3-pyridine carboxylic acid hydrazides
03/14/2013US20130065858 Compounds useful as raf kinase inhibitors
03/14/2013US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF
03/14/2013US20130065056 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
03/14/2013CA2848148A1 Benzonitrile derivatives as kinase inhibitors
03/14/2013CA2844652A1 Pde10 modulators
03/13/2013EP2567957A1 Compounds for the treatment of dyslipidemia and related diseases
03/13/2013EP2566864A2 Pyridazinones as gpr119 agonists
03/13/2013EP2566860A1 Bicyclic heteroaryl compounds as gpr119 modulators
03/13/2013EP2566859A2 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same
03/13/2013EP2566855A1 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
03/13/2013EP2566853A1 Tetrazolones as inhibitors of fatty acid synthase
03/13/2013EP2566849A1 8-hydroxy-quinoline derivatives
03/13/2013EP2566477A1 Amino-quinolines as kinase inhibitors
03/13/2013CN1953967B Purification of progesterone receptor modulators
03/13/2013CN102971324A MTOR selective kinase inhibitors
03/13/2013CN102971311A Bicyclic heteroaryl compounds as GPR119 modulators
03/13/2013CN102971310A (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists
03/13/2013CN102971309A Fungicide hydroximoyl-heterocycles derivatives
03/13/2013CN102971302A 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
03/13/2013CN102971291A Novel amide derivative and use thereof as medicine
03/13/2013CN102971290A Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof
03/13/2013CN102964294A Pyridyl inhibitors of hedgehog signalling
03/13/2013CN101479253B Insecticidal compounds
03/13/2013CN101304982B Process for the preparation of benzotriazepine derivatives
03/13/2013CN101094848B Organic compounds
03/12/2013US8394837 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
03/12/2013US8394831 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
03/12/2013US8394807 Quinazoline inhibitors of BACE 1 and methods of using
03/12/2013US8394806 2-phenyl pyrazines as tubulin inhibitors
03/12/2013US8394795 Pyrazole [3, 4-B] pyridine Raf inhibitors
03/12/2013US8394794 Therapeutic compounds
03/12/2013CA2697551C Piperidine derivatives as modulators of gpr119 activity
03/12/2013CA2695088C Novel piperazine amide derivatives
03/12/2013CA2637933C Indole sulfonamide modulators of progesterone receptors
03/12/2013CA2603826C Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
03/12/2013CA2569763C 2,4-diaminoquinazolines for spinal muscular atrophy
03/12/2013CA2553266C Substituted quinolines and their use as mycobacterial inhibitors
03/12/2013CA2517077C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/12/2013CA2388505C 5-membered heterocycle derivatives, their preparation and application as medicine
03/07/2013WO2013033268A2 Bivalent bromodomain ligands, and methods of using same
03/07/2013WO2013032591A1 Heterocyclic compounds and uses thereof
03/07/2013WO2013030367A1 Biphenylcarboxamides as rock kinase inhibitors
03/07/2013WO2013030366A1 Novel soft rock inhibitors
03/07/2013WO2013001505A3 Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases
03/07/2013WO2012117000A8 3-amino-pyridines as gpbar1 agonists
03/07/2013WO2012028332A8 Pharmaceutically active compounds as axl inhibitors
03/07/2013US20130060025 Certain heterocycles, compositions thereof, and methods for their use
03/07/2013US20130059883 Compounds and methods
03/07/2013US20130059873 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
03/07/2013US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions
03/07/2013US20130059848 Cannabinoid-2 agonists
03/07/2013US20130059847 Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
03/07/2013US20130059833 Pde10 modulators
03/07/2013US20130059830 Novel prolylcarboxypeptidase inhibitors
03/07/2013CA2846752A1 Biphenylcarboxamides as rock kinase inhibitors
03/07/2013CA2846695A1 Novel soft rock inhibitors
03/07/2013CA2846431A1 Heterocyclic compounds and uses thereof
03/07/2013CA2844521A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
03/06/2013EP2565193A1 Compositions and methods for inhibition of the JAK pathway
03/06/2013EP2564849A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
03/06/2013EP2563785A1 Compounds as agonists of s1p1 receptors
03/06/2013EP2563784A1 Fungicide hydroximoyl-heterocycles derivatives
03/06/2013EP2563783A1 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
03/06/2013EP2563782A1 Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
03/06/2013EP2563775A1 Pyrazolyl quinazoline kinase inhibitors
03/06/2013EP2563772A1 Fungicide hydroximoyl-heterocycles derivatives
03/06/2013EP2563765A1 Bicyclic compound derivatives and their use as acc inhibitors.
03/06/2013CN102958927A Indazole inhibitors of kinase
03/06/2013CN102958922A 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
03/06/2013CN102958918A Novel nicotinamide derivatives or salts thereof
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 647